Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 7, 1999 - Issue 1
31
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Testing drugs in pediatric populations: The FDA mandate

Pages 37-58 | Published online: 11 Jun 2008

References

  • American Academy of Pediatrics (AAP) Committee on Drugs . 1995 . Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations . Pediatrics , 95 : 286 – 294 .
  • American Academy of Pediatrics (AAP) Committee on Drugs . 1996 . Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration . Pediatrics , 98 : 143 – 145 .
  • Appelbaum , P.S. , Roth , L.H. , Lidz , C.W. , Benson , P. and Winslade , W. 1987 . False hopes and best data: Consent to research and the therapeutic misconception . Hastings Center Report , 17 ( 2 ) : 20 – 24 .
  • Code of Federal Regulations, 21 CFR 56 (1999). Food and Drug Administration: Institutional Review Boards, http://frwebgatel.access.gpo.gov (http://frwebgatel.access.gpo.gov)
  • 1991 . Federal policy for the protection of human subjects. (The Common Rule.) . Federal Register , 56 : 28003 – 28016 . Code of Federal Regulations, 45 CFR 46: 101–124
  • 1983 . Additional protections for children involved as subjects in research . Federal Register , 48 : 9816 – 9820 . Code of Federal Regulations, 45 CFR 46: 401–109
  • Cooke , R.E. 1994 . “ Vulnerable children ” . In Children as Research Subjects: Science, Ethics, and Law, , Edited by: Grodin , M.A. and Glantz , L.H. 193 – 214 . New York : Oxford University Press .
  • Cote’ , C.J. , Kauffman , R.E. , Troendle , G.J. and Lambert , G.H. 1996 . Is the “therapeutic orphan”; about to be adopted? . Pediatrics , 98 : 118 – 123 .
  • Food and Drug Administration (FDA) . 1997 . Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; Proposed rule . Federal Register , 62 ( 158 ) : 43900 – 43916 .
  • Food and Drug Administration (FDA) . 1998 . Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; Final rule . Federal Register , 63 ( 231 ) : 66631 – 66672 .
  • Freedman , B. 1987 . Equipoise and the ethics of clinical research . New England Journal of Medicine , 317 ( 3 ) : 141 – 145 .
  • Freedman , B. , Fuks , A. and Weijer , C. 1993 . In loco parentis: Minimal risk as an ethical threshold for research upon children . Hastings Center Report , 23 ( 2 ) : 13 – 19 .
  • Gidding , S.G. , Camp , D. , Flanagan , M.H. , Kowalski , J.A. , Lingl , L.L. , Silverman , B.L. and Langman , C.B. 1993 . A policy regarding research in healthy children . Journal of Pediatrics , 123 : 852 – 855 .
  • Glantz , L.H. 1994 . “ The law of human experimentation with children ” . In Children as Research Subjects: Science, Ethics, and Law , Edited by: Grodin , M.A. and Glantz , L.H. 103 – 130 . New York : Oxford University Press .
  • Glantz , L.H. 1998 . Research with children . American Journal of Law and Medicine , 24 ( 2 & 3 ) : 213 – 244 .
  • Janofsky , B.A. and Starfield , B. 1981 . Assessment of risk in research on children . Journal of Pediatrics , 98 : 842 – 846 .
  • Katz , J. 1993 . “Ethics and clinical research”; revisited . Hastings Center Report , 23 ( 5 ) : 31 – 39 .
  • Kauffman , R.E. 1994 . “ Scientific issues in biomedical research with children ” . In Children as Research Subjects: Science, Ethics, and Law , Edited by: Grodin , M.A. and Glantz , L.H. 29 – 45 . New York : Oxford University Press .
  • Kodish , E.D. 1998 . Informed consent in the Children's Cancer Group . Cancer , 82 ( 12 ) : 2467 – 2481 .
  • Kopelman , L.M. 1989 . “ When is the risk minimal enough for children to be used as research subjects? ” . In Children and Health Care: Moral and Social Issues , Edited by: Kopelman , L.M. and Moskop , J.C. 89 – 99 . Dordrecht : Kluwer Academic Publishers .
  • Lascari , A.D. 1981 . Risks of research in children . Journal of Pediatrics , 98 : 759 – 760 .
  • Levine , R.J. 1989 . “ Children as research subjects ” . In Children and Health Care: Moral and Social Issues , Edited by: Kopelman , L.M. and Moskop , J.C. 73 – 87 . Dordrecht : Kluwer Academic Publishers .
  • McCartney , J.J. 1978 . Research on children: National Commission says “Yes, if. . . .” . Hastings Center Report , 8 ( 5 ) : 26 – 31 .
  • National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research . 1977 . Report and Recommendations: Research Involving Children , (DHEW Publication No. (OS) 77–0004) Washington, DC : Department of Health, Education, and Welfare .
  • Nelson , R.M. 1998 . “ Children as research subjects ” . In Beyond Consent: Seeking Justice in Research, , Edited by: Kahn , J.P. , Mastroianni , A.C. and Sugarman , J. 47 – 66 . New York : Oxford University Press .
  • National Institutes of Health (NIH) . 1998 . NIH policy and guidelines on the inclusion of children as participants in research involving human subjects . March 6
  • Pear , R. 1997 . President to order drug makers to conduct pediatric studies . New York Times , August 13 : A17
  • Pear , R. 1998 . FDA will require companies to test drugs on children . New York Times , November 28 : A1 A10
  • Prentice , E.D. , Antonson , D.L. Jameton , A. 1989 . Can children be enrolled in a placebo‐controlled randomized clinical trial of synthetic growth hormone? . IRB , 11 ( 1 ) : 6 – 10 .
  • Puglisi , J.T. and Director, Human Subject Protections, Office of Protection from Research Risks . 1999 . Personal communication . January 4
  • Shirkey , H. 1968 . Editorial comment: Therapeutic orphans . Journal of Pediatrics , 72 : 119 – 120 .
  • Tauer , C.A. 1994 . The NIH trials of growth hormone for short stature . IRB , 16 ( 3 ) : 1 – 9 .
  • Weitman , S. , Ochoa , S. , Sullivan , A. , Shuster , J. , Winick , N. , Pratt , C. , Vietti , T. and Harris , M. 1997 . Pediatric phase II cancer chemotherapy trials: A pediatric oncology group study . Journal of Pediatric Hematology/Oncology , 19 ( 3 ) : 187 – 191 .
  • Zanga , J.R. November 13 1997 . “ Response of the American Academy of Pediatrics ” . November 13 , Dockets Management Branch, Food and Drug Administration .
  • Corresponding author: Tel.: (651) 690–6660. E‐mail: [email protected].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.